Detalhe da pesquisa
1.
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy.
Curr Treat Options Oncol
; 23(12): 1845-1860, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525238
2.
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data.
Neurosurg Rev
; 45(5): 3067-3081, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35984552
3.
Discontinuation of Antiseizure Medications in Patients With Brain Tumors.
Neurology
; 102(4): e209163, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290092
4.
Varenicline is a potent partial agonist at α6ß2* nicotinic acetylcholine receptors in rat and monkey striatum.
J Pharmacol Exp Ther
; 342(2): 327-34, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22550286
5.
Prognostic Implication of Patient Age in H3K27M-Mutant Midline Gliomas.
Front Oncol
; 12: 858148, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35371982
6.
Assessing the utility and attitudes toward molecular testing in neuro-oncology: a survey of the Society for Neuro-Oncology members.
Neurooncol Pract
; 8(3): 310-316, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34055378
7.
Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis.
J Nucl Med
; 62(4): 507-513, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32859705
8.
Glioblastoma as an age-related neurological disorder in adults.
Neurooncol Adv
; 3(1): vdab125, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647022
9.
A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas.
Front Neurol
; 11: 373, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32435228
10.
Role for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice.
Neuropharmacology
; 63(3): 450-9, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22579614